Ocean Biomedical Inc reports results for the quarter ended in September - Earnings Summary

Reuters04-17

* Ocean Biomedical Inc reported a quarterly adjusted loss of 53 cents per share for the quarter ended in September. The lone analyst forecast for the quarter was for a loss of 15 cents per share.

* Reported revenue was zero; analysts expected zero.

* Ocean Biomedical Inc's reported EPS for the quarter was a loss of 53 cents.

* The company reported a quarterly loss of $14.09 million.

* Ocean Biomedical Inc shares had fallen by 49.8% this quarter and gained 187.9% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts was unchanged in the last three months.

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

*

This summary was machine generated from LSEG data April 16 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2023 -0.15 -0.53 Missed

Jun. 30 2023 -0.20 -0.39 Missed

Mar. 31 2023 -0.17 -0.06 Beat

0.43

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2428383584?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-17 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2428383584","market":"us","top_or_hot":-1,"title":"Ocean Biomedical Inc reports results for the quarter ended in September - Earnings Summary","media":"Reuters","content":"<html><body><p>* <a href=\"https://laohu8.com/S/OCEA\">Ocean Biomedical</a> Inc    reported a quarterly adjusted loss of 53 cents per share for the quarter ended in September.  The lone analyst forecast for the quarter was for a loss of 15 cents per share. </p><p>   * Reported revenue was zero; analysts expected zero. </p><p>   * <a href=\"https://laohu8.com/S/1B6.SI\">Ocean</a> Biomedical Inc's reported EPS for the quarter was a loss of 53 cents.</p><p>   * The company reported a quarterly loss of $14.09 million.</p><p>   * Ocean Biomedical Inc shares had fallen by 49.8% this quarter and gained 187.9% so far this year.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p><p>RECOMMENDATIONS</p><p>   * </p><p>This summary was machine generated from LSEG data April 16 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Sep. 30 2023      -0.15          -0.53          Missed</p><p>Jun. 30 2023      -0.20          -0.39          Missed</p><p>Mar. 31 2023      -0.17          -0.06          Beat</p><p>                                 0.43           </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocean Biomedical Inc reports results for the quarter ended in September - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcean Biomedical Inc reports results for the quarter ended in September - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-17 05:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* Ocean Biomedical Inc    reported a quarterly adjusted loss of 53 cents per share for the quarter ended in September.  The lone analyst forecast for the quarter was for a loss of 15 cents per share...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCEA","symbol_name":"Ocean Biomedical","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2428383584","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428383584","pubTimestamp":1713301311,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Ocean Biomedical Inc    reported a quarterly adjusted loss of 53 cents per share for the quarter ended in September.  The lone analyst forecast for the quarter was for a loss of 15 cents per share. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"OCEA":"Ocean Biomedical"},"translate_title":"海洋生物医学公司报告截至9月的季度业绩——收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCEA":1},"content_text":"* Ocean Biomedical Inc    reported a quarterly adjusted loss of 53 cents per share for the quarter ended in September.  The lone analyst forecast for the quarter was for a loss of 15 cents per share.    * Reported revenue was zero; analysts expected zero.    * Ocean Biomedical Inc's reported EPS for the quarter was a loss of 53 cents.   * The company reported a quarterly loss of $14.09 million.   * Ocean Biomedical Inc shares had fallen by 49.8% this quarter and gained 187.9% so far this year.FORECAST CHANGES   * The mean earnings estimate of analysts was unchanged in the last three months.    * In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONS   * This summary was machine generated from LSEG data April 16 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,                                                MISSEDSep. 30 2023      -0.15          -0.53          MissedJun. 30 2023      -0.20          -0.39          MissedMar. 31 2023      -0.17          -0.06          Beat                                 0.43","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428383584"}